drugset / Trial / NCT06018948

Effect of Two Different Doses of Dexmedetomidine Infusion in Morbidly Obese Patients

NCT06018948 ↗

Phase 4 Completed 90 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

Compare the effects of two different doses of dexmedetomidine infusion on oxygenation as a primary outcome and on lung mechanics, quality of recovery and perioperative analgesia as secondary outcomes in morbidly obese patients with restrictive lung disease undergoing abdominal surgery.

Timeline

Start
2019-09-01
Primary completion
2021-09-30
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.3 ug/kg —
Comparator Dexmedetomidine Other / unclassified 0.6 ug/kg —

Indications